{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:17:44Z","timestamp":1788322664096,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":71,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005642","name":"University of Sassari","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.jtauto.2020.100048","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T07:46:50Z","timestamp":1584431210000},"page":"100048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Antibody response to homologous epitopes of Epstein-Barr virus, Mycobacterium avium subsp. paratuberculosis and IRF5 in patients with different connective tissue diseases and in mouse model of antigen-induced arthritis"],"prefix":"10.1016","volume":"3","author":[{"given":"Marco","family":"Bo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Niegowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley L.","family":"Eames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Almuttaqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giannina","family":"Arru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Erre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6606-8257","authenticated-orcid":false,"given":"Giuseppe","family":"Passiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq E.","family":"Khoyratty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erinke","family":"van Grinsven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Udalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0566-2049","authenticated-orcid":false,"given":"Leonardo A.","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2020.100048_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2741\/1506","article-title":"Citrullinated proteins in rheumatoid arthritis","volume":"10","author":"Yamada","year":"2005","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jtauto.2020.100048_bib2","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1038\/cti.2015.24","article-title":"Development of synthetic anti-cyclic citrullinated peptide antibody and its arthritogenic role","volume":"4","author":"Kim","year":"2015","journal-title":"Clinical & Translational Immunology"},{"issue":"8","key":"10.1016\/j.jtauto.2020.100048_bib3","first-page":"1691","article-title":"The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis","volume":"30","author":"Jansen","year":"2003","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jtauto.2020.100048_bib4","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2020.100048_bib5","first-page":"1","article-title":"A\u00a0potential link between environmental triggers and autoimmunity","author":"Vojdani","year":"2014","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jtauto.2020.100048_bib6","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1073\/pnas.1506254112","article-title":"IRF5 controls both acute and chronic inflammation","volume":"112","author":"Weiss","year":"2015","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.jtauto.2020.100048_bib7","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1002\/art.39321","article-title":"Promotion of inflammatory arthritis by interferon regulatory factor 5 in a mouse model","volume":"67","author":"Duffau","year":"2015","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.jtauto.2020.100048_bib8","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.4049\/jimmunol.1201162","article-title":"Monocytes from irf5 \u2212\/\u2212 mice have an intrinsic defect in their response to pristane-induced lupus","volume":"189","author":"Yang","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jtauto.2020.100048_bib9","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/febs.14654","article-title":"Advances and challenges in targeting IRF5, a key regulator of inflammation","volume":"286","author":"Almuttaqi","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.jtauto.2020.100048_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.trsl.2015.06.018","article-title":"Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease","volume":"167","author":"Eames","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.jtauto.2020.100048_bib11","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/annrheumdis-2011-200901","article-title":"IRF5 polymorphism predicts prognosis in patients with systemic sclerosis","volume":"71","author":"Sharif","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2020.100048_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/vim.2015.0035","article-title":"Increased epstein-barr virus DNA load and antibodies against EBNA1 and EA in Sardinian patients with rheumatoid arthritis","volume":"28","author":"Erre","year":"2015","journal-title":"Viral Immunol."},{"key":"10.1016\/j.jtauto.2020.100048_bib13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/1756-185X.13087","article-title":"Down-regulation of increased TRAF6 expression in the peripheral mononuclear cells of patients with primary Sj\u00f6gren\u2019s syndrome by an EBV-EBER1-specific synthetic single-stranded complementary DNA molecule","volume":"20","author":"Sipka","year":"2017","journal-title":"International Journal of Rheumatic Diseases"},{"key":"10.1016\/j.jtauto.2020.100048_bib14","author":"Ascherio"},{"key":"10.1016\/j.jtauto.2020.100048_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13075-017-1237-9","article-title":"Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes","volume":"19","author":"Farina","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2020.100048_bib16","first-page":"376","article-title":"Interferon regulatory factor 5 is a potential target of autoimmune response triggered by Epstein-barr virus and Mycobacterium avium subsp. paratuberculosis in rheumatoid arthritis: investigating a mechanism of molecular mimicry","volume":"36","author":"Bo","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2020.100048_bib17","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1038\/s41598-017-03370-z","article-title":"Altered humoral immunity to mycobacterial antigens in Japanese patients affected by inflammatory demyelinating diseases of the central nervous system","volume":"7","author":"Cossu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2020.100048_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2018.07.007","article-title":"High levels of antibodies against PtpA and PknG secreted by Mycobacterium avium ssp. paratuberculosis are present in neuromyelitis optica spectrum disorder and multiple sclerosis patients","volume":"323","author":"Slavin","year":"2018","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2020.100048_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176584","article-title":"Increased seroreactivity to proinsulin and homologous mycobacterial peptides in latent autoimmune diabetes in adults","volume":"12","author":"Niegowska","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jtauto.2020.100048_bib20","doi-asserted-by":"crossref","first-page":"22266","DOI":"10.1038\/srep22266","article-title":"Type 1 Diabetes at-risk children highly recognize Mycobacterium avium subspecies paratuberculosis epitopes homologous to human Znt8 and Proinsulin","volume":"6","author":"Niegowska","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2020.100048_bib21","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/s41598-018-19957-z","article-title":"Rheumatoid arthritis patient antibodies highly recognize IL-2 in the immune response pathway involving IRF5 and EBV antigens","volume":"8","author":"Bo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2020.100048_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrmicro754","article-title":"Microorganisms and autoimmunity: making the barren field fertile?","volume":"1","author":"von Herrath","year":"2003","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jtauto.2020.100048_bib23","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/jcm8091309","article-title":"Rheumatoid arthritis-associated mechanisms of Porphyromonas gingivalis and aggregatibacter actinomycetemcomitans","volume":"8","author":"G\u00f3mez-Ba\u00f1uelos","year":"2019","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.jtauto.2020.100048_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/art.21629","article-title":"Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti\u2013citrullinated protein antibodies in rheumatoid arthritis","volume":"54","author":"Pratesi","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2020.100048_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","article-title":"Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity","volume":"50","author":"Harley","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jtauto.2020.100048_bib26","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2020.100048_bib27","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2020.100048_bib28","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2020.100048_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"American college of rheumatology\/European league against rheumatism classification criteria for primary sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2016","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.jtauto.2020.100048_bib30","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman Dd","year":"2002","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jtauto.2020.100048_bib31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","article-title":"European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes","volume":"60","author":"Valentini","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2020.100048_bib32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sj\u00f6gren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2020.100048_bib33","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/art.27503","article-title":"Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis?","volume":"62","author":"Bevaart","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2020.100048_bib34","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jtauto.2020.100048_bib35","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/ard.2010.148551","article-title":"Animal models for arthritis: innovative tools for prevention and treatment","volume":"70","author":"Kollias","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2020.100048_bib36","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1002\/art.24075","article-title":"Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis","volume":"58","author":"Egan","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2020.100048_bib37","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm.1987","article-title":"Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease","volume":"15","author":"Midwood","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.jtauto.2020.100048_bib38","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/eji.200939578","article-title":"Animal models of rheumatoid arthritis","volume":"39","author":"Asquith","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2020.100048_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biocel.2018.03.012","article-title":"Diverse mechanisms of IRF5 action in inflammatory responses","volume":"99","author":"Khoyratty","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jtauto.2020.100048_bib40","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/jid.2013.423","article-title":"Epstein\u2013Barr virus infection induces aberrant TLR activation pathway and fibroblast\u2013myofibroblast conversion in Scleroderma","volume":"134","author":"Farina","year":"2014","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.jtauto.2020.100048_bib41","series-title":"Scleroderma, Myositis and Related Syndromes","article-title":"AB0751The epstein-barr virus infection in systemic sclerosis","author":"Efthymiou","year":"2018"},{"key":"10.1016\/j.jtauto.2020.100048_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2019.04.006","article-title":"A\u00a0cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis","volume":"101","author":"Severa","year":"2019","journal-title":"J.\u00a0Autoimmun."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909020300150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909020300150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:37:33Z","timestamp":1762904253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909020300150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":42,"alternative-id":["S2589909020300150"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2020.100048","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody response to homologous epitopes of Epstein-Barr virus, Mycobacterium avium subsp. paratuberculosis and IRF5 in patients with different connective tissue diseases and in mouse model of antigen-induced arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2020.100048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100048"}}